In February, OkCredit, which is backed by marquee traders together with Tiger Global and Lightspeed, laid off around forty staff. Just earlier this week, used cars platform Cars24 requested 600 workers to go away and edtech startup Vedantu laid off 424 staff. MFine, a Bengaluru, India-based leading Digital Health startup, raised a $48 million Series C funding spherical co-led by Moore Strategic Ventures and BEENEXT. The newest round of funding comes months after the startup secured $16 million in January from Heritas Capital and YS Investment, a Singapore-based family office. The startup, again then, said that it will use the funds to increase its funding in AI improvement, cellular engineering, and system integration. Digital well being startup MFine secured $48 million (~Rs 356.1 crore) in a Series C funding spherical anchored by Moore Strategic Ventures and BEENEXT.
In the past month, Vedantu had laid off about 625 employees across two tranches including 424 workers early this week. While the company is but to file annual monetary results for FY22, MFine had registered a 152% development in its working income to Rs 12.9 crore in FY21 from Rs 5.12 crore in FY20, in accordance with its annual monetary assertion filed with RoC. Its annual losses noticed a nominal enhance of 3.4% to Rs 102.7 crore during FY21 from Rs ninety nine.35 crore in FY20. In September final 12 months, mFine had raised $48 million in a Series C spherical co-led by Moore Strategic Ventures and Beenext. Founded in December 2017 by Ashutosh Lawania and Prasad Kompalli, MFine has greater than 6,000 docs across 35 specialties on its platform and serves users in additional than 1,000 towns across India.
MFine, an Indian digital well being startup with an online platform that permits folks to entry exams, docs and more, has raised $48m in Series C funding. Founded in 2017, MFine says it was utilizing the funding to develop new merchandise to for patients suffering mfine bangalorebased 48m series ventures from acute and persistent illness. MFine, founded in 2017 by Prasad Kompalli and Ashutosh Lawania, is an on-demand healthcare platform pushed by AI that gives its customers entry to digital consultations and connected care programmes from major hospitals across the nation.
LifeCell’s main line of business is stem cell banking, which in FY21 produced almost 60% of the operating revenue or Rs 139 crore. The staff leverages the power of advanced technologies around cells, genes and tissues to ship industry-leading companies towards propelling and enabling the best future for each era. In 2019, the startup raised $17.2 million in a Series B funding led by SBI Investment, SBI Ven Capital, and BEENEXT. The company is projected to be valued at round $450 million to $500 million after the newest funding spherical. The $120 billion Health Delivery market in India is fast-paced in the course of digitization, and much like other sectors like funds, banking and training, technology players are building digital first companies and vying for a significant share of the market. In the coming months, MFine might be extending the software to measure coronary heart rate and blood pressure, the statement stated.
DealStreetAsia first reported this development based on the company’s regulatory filings accessed by DealStreetAsia – DATA VANTAGE. The slowdown in funding actions are impacting startups regardless of their measurement, stage and valuation. To conserve resources, reduce burn and put together for lengthy winter, a number of companies had resorted to layoffs.